Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 31 | 1 | 43 | +13 |
| Shares | 11.4M | 34.5K | 12.5M | +1.12M (+9.9%) |
| Value | $92.1M | $279.8K | $119.5M | +$27.7M (+30.2%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $23.1M | 17.34% |
| Opaleye Management Inc. | 272,200 | $2.61M | 0.91% |
| Gendell Jeffrey L | 153,070 | $1.47M | 0.13% |
| Susquehanna International Group, LLP | 107,613 | $1.03M | 0.00% |
| CIBC World Markets Inc. | 99,363 | $954.0K | 0.00% |
| 1492 Capital Management LLC | 94,870 | $910.8K | 0.59% |
| Two Sigma Investments, LP | 87,671 | $841.6K | 0.00% |
| Apis Capital Advisors, LLC | 58,000 | $556.8K | 0.65% |
| Two Sigma Advisers, LP | 55,000 | $528.0K | 0.00% |
| Bridgeway Capital Management, LLC | 34,200 | $328.3K | 0.01% |
| Jump Financial, LLC | 20,991 | $201.5K | 0.01% |
| Goldman Sachs Group Inc | 20,985 | $201.5K | 0.00% |
| Qube Research & Technologies Ltd | 17,272 | $165.8K | 0.00% |
| Citigroup Inc | 16,848 | $162.8K | 0.00% |
| Man Group plc | 13,630 | $130.8K | 0.00% |
| NewEdge Wealth, LLC | 10,000 | $96.0K | 0.00% |
| Barclays PLC | 9,260 | $88.9K | 0.00% |
| Simplex Trading, LLC | 2,921 | $28.0K | 0.00% |
Sold out (5)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Sonic Fund II, L.P. | 2,407,357 | $19.5M |
| Valley Forge Investment Consultants Inc Adv | 40,000 | $324.0K |
| Wealthspire Advisors, LLC | 25,000 | $202.0K |
| Group One Trading, L.P. | 14,924 | $121.0K |
| Cutler Group LP | 139 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 34,539 | $279.8K |